Not surprisingly, efforts to treat LHRH-R positive tumors have focused on the development of antagonists that can block production of LH and FSH and thereby prevent the biosynthesis of androgens and estrogens that promote tumor growth. The gene discussed is GNRHR; the disease is neoplasm.